Skip to main content
NCBI home page
Journal of Clinical Pathology logoLink to Journal of Clinical Pathology
. 1992 Dec;45(12):1058–1061. doi: 10.1136/jcp.45.12.1058

Search for retrovirus in the chronic fatigue syndrome.

J W Gow 1, K Simpson 1, A Schliephake 1, W M Behan 1, L J Morrison 1, H Cavanagh 1, A Rethwilm 1, P O Behan 1
PMCID: PMC494996  PMID: 1479030

Abstract

AIM: To examine peripheral blood and skeletal muscle from patients with chronic fatigue syndrome for exogenous retrovirus. METHODS: Blood samples from 30 patients and muscle biopsy specimens of 15 patients were examined for retroviral sequences by DNA extraction, polymerase chain reaction (PCR), and Southern blotting hybridisation. Sera were examined for human foamy virus by western immunoblotting and indirect immunofluorescence techniques. RESULTS: No differences between the patient and control populations was found for any of the PCR primer sets used (gag, pol, env, and tax regions of HTLV I/II). An endogenous gag band was observed in both the patient and control groups. All sera were negative for antibody to human foamy virus. CONCLUSION: The results indicate that there is no evidence of retroviral involvement in the chronic fatigue syndrome.

Full text

PDF
1058

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Abbott M. A., Poiesz B. J., Byrne B. C., Kwok S., Sninsky J. J., Ehrlich G. D. Enzymatic gene amplification: qualitative and quantitative methods for detecting proviral DNA amplified in vitro. J Infect Dis. 1988 Dec;158(6):1158–1169. doi: 10.1093/infdis/158.6.1158. [DOI] [PubMed] [Google Scholar]
  2. Behan P. O., Bakheit A. M. Clinical spectrum of postviral fatigue syndrome. Br Med Bull. 1991 Oct;47(4):793–808. doi: 10.1093/oxfordjournals.bmb.a072511. [DOI] [PubMed] [Google Scholar]
  3. Behan P. O., Behan W. M. Postviral fatigue syndrome. Crit Rev Neurobiol. 1988;4(2):157–178. [PubMed] [Google Scholar]
  4. Behan W. M., More I. A., Behan P. O. Mitochondrial abnormalities in the postviral fatigue syndrome. Acta Neuropathol. 1991;83(1):61–65. doi: 10.1007/BF00294431. [DOI] [PubMed] [Google Scholar]
  5. DeFreitas E., Hilliard B., Cheney P. R., Bell D. S., Kiggundu E., Sankey D., Wroblewska Z., Palladino M., Woodward J. P., Koprowski H. Retroviral sequences related to human T-lymphotropic virus type II in patients with chronic fatigue immune dysfunction syndrome. Proc Natl Acad Sci U S A. 1991 Apr 1;88(7):2922–2926. doi: 10.1073/pnas.88.7.2922. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Ehrlich G. D., Glaser J. B., Bryz-Gornia V., Maese J., Waldmann T. A., Poiesz B. J., Greenberg S. J. Multiple sclerosis, retroviruses, and PCR. The HTLV-MS Working Group. Neurology. 1991 Mar;41(3):335–343. doi: 10.1212/wnl.41.3.335. [DOI] [PubMed] [Google Scholar]
  7. HENDERSON D. A., SHELOKOV A. Epidemic neuromyasthenia; clinical syndrome. N Engl J Med. 1959 Apr 9;260(15):757–contd. doi: 10.1056/NEJM195904092601506. [DOI] [PubMed] [Google Scholar]
  8. Holmes G. P., Kaplan J. E., Gantz N. M., Komaroff A. L., Schonberger L. B., Straus S. E., Jones J. F., Dubois R. E., Cunningham-Rundles C., Pahwa S. Chronic fatigue syndrome: a working case definition. Ann Intern Med. 1988 Mar;108(3):387–389. doi: 10.7326/0003-4819-108-3-387. [DOI] [PubMed] [Google Scholar]
  9. Koprowski H., DeFreitas E. C., Harper M. E., Sandberg-Wollheim M., Sheremata W. A., Robert-Guroff M., Saxinger C. W., Feinberg M. B., Wong-Staal F., Gallo R. C. Multiple sclerosis and human T-cell lymphotropic retroviruses. Nature. 1985 Nov 14;318(6042):154–160. doi: 10.1038/318154a0. [DOI] [PubMed] [Google Scholar]
  10. Kwok S., Higuchi R. Avoiding false positives with PCR. Nature. 1989 May 18;339(6221):237–238. doi: 10.1038/339237a0. [DOI] [PubMed] [Google Scholar]
  11. Kwok S., Kellogg D., Ehrlich G., Poiesz B., Bhagavati S., Sninsky J. J. Characterization of a sequence of human T cell leukemia virus type I from a patient with chronic progressive myelopathy. J Infect Dis. 1988 Dec;158(6):1193–1197. doi: 10.1093/infdis/158.6.1193. [DOI] [PubMed] [Google Scholar]
  12. Morrison L. J., Behan W. H., Behan P. O. Changes in natural killer cell phenotype in patients with post-viral fatigue syndrome. Clin Exp Immunol. 1991 Mar;83(3):441–446. doi: 10.1111/j.1365-2249.1991.tb05658.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Netzer K. O., Rethwilm A., Maurer B., ter Meulen V. Identification of the major immunogenic structural proteins of human foamy virus. J Gen Virol. 1990 May;71(Pt 5):1237–1241. doi: 10.1099/0022-1317-71-5-1237. [DOI] [PubMed] [Google Scholar]
  14. Neumann-Haefelin D., Rethwilm A., Bauer G., Gudat F., zur Hausen H. Characterization of a foamy virus isolated from Cercopithecus aethiops lymphoblastoid cells. Med Microbiol Immunol. 1983;172(2):75–86. doi: 10.1007/BF02124508. [DOI] [PubMed] [Google Scholar]
  15. Osame M., Usuku K., Izumo S., Ijichi N., Amitani H., Igata A., Matsumoto M., Tara M. HTLV-I associated myelopathy, a new clinical entity. Lancet. 1986 May 3;1(8488):1031–1032. doi: 10.1016/s0140-6736(86)91298-5. [DOI] [PubMed] [Google Scholar]
  16. Ramsay A. M. 'Epidemic neuromyasthenia' 1955-1978. Postgrad Med J. 1978 Nov;54(637):718–721. doi: 10.1136/pgmj.54.637.718. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Salahuddin S. Z., Markham P. D., Wong-Staal F., Franchini G., Kalyanaraman V. S., Gallo R. C. Restricted expression of human T-cell leukemia--lymphoma virus (HTLV) in transformed human umbilical cord blood lymphocytes. Virology. 1983 Aug;129(1):51–64. doi: 10.1016/0042-6822(83)90395-1. [DOI] [PubMed] [Google Scholar]
  18. Southern P., Oldstone M. B. Medical consequences of persistent viral infection. N Engl J Med. 1986 Feb 6;314(6):359–367. doi: 10.1056/NEJM198602063140606. [DOI] [PubMed] [Google Scholar]
  19. Straus S. E. History of chronic fatigue syndrome. Rev Infect Dis. 1991 Jan-Feb;13 (Suppl 1):S2–S7. doi: 10.1093/clinids/13.supplement_1.s2. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Pathology are provided here courtesy of BMJ Publishing Group

RESOURCES